It is important to recognize that the efficacy demonstrated in approval trials does not always translate into effectiveness in general practice, particularly because the population enrolled in clinical trials is generally younger and has fewer comorbidities than the typical patient with cancer seen by clinicians each day <a href=http://lasix.mom>lasix blood thinner</a> A problem with such retrospective classification is that it is not applicable in the acute situation when the child has symptoms